Montelukast sodium and Spinal pain - a phase IV clinical study of FDA data

Summary:

Spinal pain is reported as a side effect among people who take Montelukast sodium (montelukast sodium), especially for people who are female, 40-49 old, also take Folic Acid, and have Relapsing-remitting multiple sclerosis.

The phase IV clinical study analyzes which people have Spinal pain when taking Montelukast sodium. It is created by eHealthMe based on reports of 24,779 people who have side effects when taking Montelukast sodium from the FDA, and is updated regularly.

What is Montelukast sodium?

Montelukast sodium has active ingredients of montelukast sodium. It is often used in asthma. eHealthMe is studying from 26,093 Montelukast sodium users. Check the latest studies of Montelukast sodium.

What is Spinal pain?

Spinal pain (pain in spine) is found to be associated with 787 drugs and 688 conditions by eHealthMe. Check the latest studies of Spinal pain.

On Jul, 11, 2026

24,779 people reported to have side effects when taking Montelukast sodium.
Among them, 31 people (0.13%) have Spinal pain.

Could Montelukast sodium cause Spinal pain?

Among these 31 people:

What is the gender of people who have Spinal pain when taking Montelukast sodium? *

female: 87.1 %
male: 12.9 %

What is the age of people who have Spinal pain when taking Montelukast sodium? *

What are other drugs people take besides Montelukast sodium? *

Ramipril: 13 people, 41.94%
Folic Acid: 13 people, 41.94%
Amlodipine: 12 people, 38.71%
Dalfampridine: 11 people, 35.48%
Ocrevus: 10 people, 32.26%
Zyrtec: 8 people, 25.81%
Cyclobenzaprine Hydrochloride: 5 people, 16.13%
Magnesium: 5 people, 16.13%
Potassium: 5 people, 16.13%
Pantoprazole Sodium: 5 people, 16.13%

What are other side effects people have besides Spinal pain? *

Fatigue (feeling of tiredness): 26 people, 83.87%
Gait Disturbance: 17 people, 54.84%
Headache (pain in head): 14 people, 45.16%
Blood Pressure Fluctuation: 14 people, 45.16%
Circulatory Collapse: 13 people, 41.94%
Rashes (redness): 13 people, 41.94%
Arrhythmias (irregular heartbeat): 13 people, 41.94%
Swelling: 13 people, 41.94%
Fainting (loss of consciousness and postural tone): 13 people, 41.94%
Pain: 11 people, 35.48%

What are the existing conditions these people have? *

Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 9 people, 29.03%
Immunodeficiency Common Variable: 5 people, 16.13%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 3 people, 9.68%
Ankylosing Spondylitis (type of arthritis affecting the spine): 2 people, 6.45%
Dyspnea (difficult or laboured breathing): 2 people, 6.45%
Malignant Melanoma (skin cancer rises from melancytes): 2 people, 6.45%
Hypertensive Heart Disease: 2 people, 6.45%
Arrhythmias (irregular heartbeat): 1 person, 3.23%
Bone Disorder: 1 person, 3.23%
Diabetes: 1 person, 3.23%

* Approximation only. Some reports may have incomplete information.

Do you take Montelukast sodium and have Spinal pain?

- Check whether Spinal pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Montelukast sodium:

Montelukast sodium (26,093 reports)

Spinal pain treatments and more:

Spinal pain (17,834 reports)

Browse all side effects of Montelukast sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Spinal pain:

Spinal pain (787 drugs)

Browse all the conditions that are associated with Spinal pain:

Spinal pain (688 conditions)

Related publications that referenced our studies

Das S, Mondal S, Dey JK, Bandyopadhyay S, Saha I, Tripathi SK, "A case of montelukast induced hypercholesterolemia, severe hypertriglyceridemia and pancreatitis", Journal of Young Pharmacists, 2013 Jun .
Das S, Mondal S, Dey JK, Bandyopadhyay S, Saha I, Tripathi SK, "A case of montelukast induced hypercholesterolemia, severe hypertriglyceridemia and pancreatitis", Journal of Young Pharmacists, 2013 Jun .

How the study uses the data?

The study uses data from the FDA. It is based on montelukast sodium (the active ingredients of Montelukast sodium) and Montelukast sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.